中国育龄期肥胖女性中多囊卵巢综合征的患病率:伴或不伴代谢综合征的比较
该横断面临床研究纳入299例代谢不健康肥胖(MUO)和122例体质指数匹配的代谢健康肥胖(MHO)中国育龄期女性,比较两组多囊卵巢综合征(PCOS)患病率。结果示MUO组PCOS患病率67.89%与MHO组66.96%无差异,校正混杂因素后代谢综合征(MetS)不能预测PCOS存在。
要点
- MUO组PCOS患病率67.89%与MHO组66.96%无显著差异。
- 校正混杂因素后,MetS不能预测PCOS的存在。
- MHO组内脏脂肪组织较低、胰岛素敏感性相对较高、β细胞功能较好。
核心结论
- 研究首次提示MetS不增加PCOS的额外风险。
- MUO与MHO均在一定程度上与胰岛素抵抗相关。
研究设计与样本
- 横断面临床研究,纳入299例MUO和122例BMI匹配的中国育龄期女性。
- MHO定义为肥胖且代谢异常不超过一项。
- PCOS诊断基于修订的Rotterdam标准。
主要发现
- MUO组PCOS患病率67.89% vs MHO组66.96%,两组PCOS及其组分患病率无差异。
- logistic回归分析中,校正混杂因素后MetS不能预测PCOS的存在。
- MHO组较MUO组内脏脂肪组织较低、胰岛素敏感性相对较高、β细胞功能较好。
- MHO与MUO女性间性激素(游离睾酮和性激素结合球蛋白除外)及超声表现无显著差异。
关键数值与推荐
- MHO定义为肥胖且代谢异常不超过一项。
- PCOS诊断基于修订的Rotterdam标准。
- 胰岛素抵抗通过稳态模型评估胰岛素抵抗指数或Bergman最小模型衍生的胰岛素敏感性指数判定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the prevalence of polycystic ovary syndrome (PCOS) and related clinical characteristics between metabolically unhealthy obese (MUO) and metabolically healthy obese (MHO) women of reproductive age. DESIGN: Cross-sectional clinical study. SETTING: Tertiary hospital. PATIENT(S): We studied 299 MUO and 122 MHO Chinese women matched on body mass index. Metabolically healthy obese was defined as obesity with no more than one metabolic abnormality. Diagnosis of PCOS was based on the revised Rotterdam criteria. INTERVENTION(S): Each subject underwent physical examination, laboratory evaluation, and gynecologic ultrasound for a diagnosis of PCOS or metabolic syndrome (MetS). MAIN OUTCOME MEASURE(S): Prevalence of PCOS was calculated in both groups. Insulin resistance was determined by homeostasis model assessment of insulin resistance or by the insulin sensitivity index derived from Bergman's minimal model. Fat distribution was measured with computerized tomography scan. RESULT(S): Prevalence of PCOS and its components did not differ between MUO and BMI-matched MHO groups (67.89% and 66.96%, respectively). In logistic regression analysis, MetS did not predict the presence of PCOS after adjusting for confounding factors. The MHO group had lower visceral adipose tissue, relatively higher insulin sensitivity, and better β-cell function, compared with those in the MUO group; but there were no significant differences in sex hormones (except for free T and sex hormone-binding globulin) and ultrasound manifestations between MHO and MUO women. CONCLUSION(S): For the first time, our findings suggest that MetS does not add additional risk for PCOS. In addition, we found that both MUO and MHO are associated with insulin resistance to some extent.
引用
- Liang P, Xi L, Shi J, et al. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Fertil Steril. 2017. PMID: 28238496. doi:10.1016/j.fertnstert.2016.12.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。